chr20-45893314-A-G
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_000308.4(CTSA):c.692+3A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000548 in 1,458,546 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000308.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTSA | NM_000308.4 | c.692+3A>G | splice_region_variant, intron_variant | ENST00000646241.3 | NP_000299.3 | |||
CTSA | NM_001127695.3 | c.692+3A>G | splice_region_variant, intron_variant | NP_001121167.1 | ||||
CTSA | NM_001167594.3 | c.641+3A>G | splice_region_variant, intron_variant | NP_001161066.2 | ||||
CTSA | NR_133656.2 | n.744+3A>G | splice_region_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTSA | ENST00000646241.3 | c.692+3A>G | splice_region_variant, intron_variant | NM_000308.4 | ENSP00000493613.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1458546Hom.: 0 Cov.: 31 AF XY: 0.00000689 AC XY: 5AN XY: 725902
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Combined deficiency of sialidase AND beta galactosidase Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | The CTSA c.746+3A>G variant, also known as the SpDEx7 variant, has been reported in six studies in which it is found in a total of 14 individuals with galactosialidosis, all of Japanese origin, including nine in a homozygous state and five in a compound heterozygous state (Shimmoto et al. 1990; Shimmoto et al. 1993; Zhou et al. 1993; Tatano et al. 2006; Yamazaki et al. 2014; Hossain et al. 2016). Control data are unavailable for this variant which is also not found in the 1000 Genomes Project, the Exome Sequencing Project, or the Exome Aggregation Consortium. Functional studies by Shimmoto et al. (1993) have demonstrated that the variant causes aberrant splicing and skipping of exon 7 while allowing the production of a small amount of correctly spliced mRNA. This is thought to result in the milder late-onset phenotype seen in individuals who are homozygous for the variant while a more severe phenotype is seen in individuals who are compound heterozygotes for this variant in combination with different missense variants. Reduced capthepsin activity (one percent of normal levels) was demonstrated in an individual who was a compound heterozygote for the variant (Zhou et al. 1993). Based on the evidence, the c.746+3A>G variant is classified as pathogenic for galactosialidosis. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 04, 2023 | For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 376). This variant is also known as IVS7+3A>G. This variant has been observed in individual(s) with galactosialidosis (PMID: 31044084, 32774297). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 7 of the CTSA gene. It does not directly change the encoded amino acid sequence of the CTSA protein. It affects a nucleotide within the consensus splice site. - |
Galactosialidosis, adult Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 25, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at